Researchers at the National University of Singapore have developed an experimental electronic implant that draws its power from glucose in the body, continuously monitors glucose levels, and automatically stimulates the vagus nerve when they rise. The technology showed promising results in improving blood sugar control and reducing inflammation in animal models with diabetes.
The scientific website Medical Express reported the day before yesterday that the study was published in the journal Nature on the 18th of the same month. It explained that the implant, called NeuroAxis, combines monitoring of changes in glucose levels with automatic neural intervention, without the need for external batteries or wireless charging.
How the Implant Works
The implant relies on a small biofuel cell that converts glucose in the fluid surrounding tissues into electrical energy, using gold and platinum nanomaterials. This makes it possible to power its electronic components and continuously track changes in sugar levels.
The implant records glucose readings every 30 minutes, and when five consecutive readings show a rise above the set threshold, it sends electrical pulses to the vagus nerve for three minutes. The aim is to activate the body's natural mechanisms involved in regulating metabolism and the inflammatory response.
The vagus nerve plays an important role in transmitting signals between the brain and a number of internal organs, including the liver, pancreas and intestines, and it also helps regulate metabolic functions and the immune response.
Test Results
The researchers tested the implant on mouse models with type 1 and type 2 diabetes, and the results showed improved blood sugar regulation in both groups.
The researchers also observed a decrease in inflammation markers and a reduction in fat accumulation in the body and liver of the animals. The improvement continued throughout the six-week study period, even after active neural stimulation stopped and the device entered standby mode.
The researchers noted that this technology represents a new research approach in the field of electronic treatment of metabolic disorders, as it combines sensing of biological changes with automatic neural intervention, instead of relying on devices that need an external power source or continuous intervention.
Stage of Development
The implant is still at the animal testing stage, as its development requires improving the stability of the biofuel cell and the accuracy of determining the sugar levels that call for stimulation. It also requires further studies to assess its safety and effectiveness before clinical testing on humans.
Source: Syrian Arab News Agency (SANA)

Comments (0)